Related Experiment Video
Updated: Jun 24, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Bronchiolitis: from empiricism to scientific evidence
S Carraro1, S Zanconato, E Baraldi
1Unit of Pneumology and Allergology, Pediatric Department, University of Padua, Padua, Italy.
Bronchiolitis, a common infant respiratory infection caused by RSV, requires updated management strategies. This review synthesizes new international guidelines on diagnosis, treatment, and prevention for infants.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Bronchiolitis is the most frequent viral infection of the lower respiratory tract in infants, peaking between 3-9 months.
- Inflammatory obstruction of small airways characterizes the clinical presentation.
- Respiratory syncytial virus (RSV) is the primary etiological agent, implicated in over 50% of cases.
Purpose of the Study:
- To provide an updated overview of pediatric bronchiolitis management.
- To discuss key aspects of diagnosis, treatment, and prevention.
- To align clinical practice with recent international guidelines.
Main Methods:
- Review of the first international guidelines on bronchiolitis management.
- Synthesis of recommendations from the American Academy of Pediatrics (AAP) and the Scottish Intercollegiate Guidelines Network (SIGN).
- Discussion of salient points for clinical application.
Main Results:
- New international guidelines offer updated approaches to bronchiolitis care.
- Emphasis on evidence-based strategies for diagnosis, treatment, and prevention.
- Harmonization of recommendations from major pediatric and respiratory societies.
Conclusions:
- Updated management strategies for infant bronchiolitis are crucial.
- Adherence to new international guidelines can improve patient outcomes.
- Further research may refine evidence-based care for this common childhood illness.
Related Concept Videos
Asthma I: Introduction
Criteria for Causality: Bradford Hill Criteria - II
Respiratory Syncytial Virus Disease
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Microbiota of the Respiratory Tract
Pulmonary Cycle: Exhalation
